Your Input: | |||||
UFL1 | E3 UFM1-protein ligase 1 isoform X1. (791 aa) | ||||
LATS1 | Serine/threonine-protein kinase LATS1. (958 aa) | ||||
MED1 | Mediator of RNA polymerase II transcription subunit 1; Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene- specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. (1512 aa) | ||||
CNOT1 | CCR4-NOT transcription complex subunit 1 isoform X4. (2376 aa) | ||||
CNOT9 | Cell differentiation protein RCD1 homolog. (299 aa) | ||||
DDRGK1 | DDRGK domain-containing protein 1. (315 aa) | ||||
AR | Androgen receptor. (886 aa) | ||||
FSHR | Follicle-stimulating hormone receptor; G protein-coupled receptor for follitropin, the follicle- stimulating hormone. Through cAMP production activates the downstream PI3K-AKT and ERK1/ERK2 signaling pathways. (695 aa) | ||||
FOXA1 | Hepatocyte nuclear factor 3-alpha. (442 aa) | ||||
FOXH1 | Forkhead box H1. (360 aa) | ||||
PAK1 | Serine/threonine-protein kinase PAK 1. (550 aa) | ||||
DNAAF4 | Dyslexia susceptibility 1 candidate gene 1 protein isoform X1. (416 aa) | ||||
BRCA1 | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] (1825 aa) | ||||
ZNF366 | Zinc finger protein 366. (739 aa) | ||||
UBA5 | Ubiquitin-like modifier-activating enzyme 5 isoform X1. (404 aa) | ||||
SRARP | Uncharacterized protein C1orf64 homolog. (170 aa) | ||||
KANK2 | KN motif and ankyrin repeat domain-containing protein 2. (739 aa) | ||||
KMT2D | Histone-lysine N-methyltransferase 2D. (4855 aa) | ||||
UFSP2 | Ufm1-specific protease 2. (441 aa) | ||||
PHB2 | Prohibitin 2. (298 aa) | ||||
CNOT2 | CCR4-NOT transcription complex subunit 2 isoform X2. (542 aa) | ||||
PAGR1 | PAXIP1-associated glutamate-rich protein 1. (254 aa) | ||||
YAP1 | Transcriptional coactivator YAP1 isoform X4. (488 aa) | ||||
VPS18 | Vacuolar protein sorting-associated protein 18 homolog isoform X1. (973 aa) | ||||
SRC | Proto-oncogene tyrosine-protein kinase Src. (538 aa) | ||||
TP63 | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. (680 aa) |